Applicant, as named in the Orange Book

Exeltis Usa Inc

Next listed expiry: Slynd on 28 Jun 2031. 1 products with live protection, 1 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Slynd drospirenone	drospirenone	211367	28 Jun 2031	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.

Products without listed protection (1)

Drug	Ingredient	NDA	Earliest generic entry	Basis
Tyblume ethinyl estradiol; levonorgestrel	ethinyl estradiol; levonorgestrel	209405	open now	no listed protection